Literature DB >> 26027807

Schizophrenia and Toxoplasma gondii: an undervalued association?

Jaroslav Flegr1.   

Abstract

The existence of an association between schizophrenia and an infection by the protozoan parasite Toxoplasma gondii has been suspected since the 1950s. Two significant phenomena first garnered the attention of the psychiatric community toward toxoplasmosis, the illness precipitated by an infection of the parasite. Transient symptoms of acute toxoplasmosis sometimes resemble the clinical picture of paranoid schizophrenia. Many studies have also found an increased seroprevalence of toxoplasmosis in clients of mental health institutions in comparison with members of control populations. We have had to wait until the first decade of our millennium for several independent research teams to make discoveries that would shed light on the possible mechanisms that link the Toxoplasma parasite to schizophrenia.

Entities:  

Keywords:  dopamine; manipulation hypothesis; mental disorder; parasite; schizophrenia; toxoplasmosis

Mesh:

Substances:

Year:  2015        PMID: 26027807     DOI: 10.1586/14787210.2015.1051033

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  17 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

2.  Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability.

Authors:  Jeffery D Zwicker; Nicolas A Diaz; Alfredo J Guerra; Paul D Kirchhoff; Bo Wen; Duxin Sun; Vern B Carruthers; Scott D Larsen
Journal:  Bioorg Med Chem Lett       Date:  2018-03-09       Impact factor: 2.823

Review 3.  Toxoplasma gondii and schizophrenia: a review of published RCTs.

Authors:  Sam D Chorlton
Journal:  Parasitol Res       Date:  2017-05-15       Impact factor: 2.289

4.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Luis-Miguel Ortega-Mora; Javier Moreno-Gonzalo; Ignacio Ferre; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Lynn K Barrett; Dustin J Maly; Kayode K Ojo; Wes Van Voorhis; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

Review 5.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

6.  Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection.

Authors:  Gungor Cagdas Dincel; Hasan Tarik Atmaca
Journal:  Int J Immunopathol Pharmacol       Date:  2016-03-10       Impact factor: 3.219

7.  High Seroprevalence of Toxoplasma Gondii Infection in Female Sex Workers: A Case-Control Study.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Jesús Hernández-Tinoco; Emilio Arreola-Cháidez; Juan López; Karla Itzel Salcido-Meraz; Sergio Estrada-Martínez; José Antonio Navarrete-Flores; Alma Rosa Pérez-Álamos; Marcia Hernández-Ochoa; Elizabeth Rábago-Sánchez; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-11-04

Review 8.  A systematic review and meta-analysis of the seroprevalence of Toxoplasma gondii in cats in mainland China.

Authors:  Huan Ding; Yu-Meng Gao; Yao Deng; Poppy H L Lamberton; Da-Bing Lu
Journal:  Parasit Vectors       Date:  2017-01-13       Impact factor: 3.876

9.  Toxoplasma gondii Infection and Mixed Anxiety and Depressive Disorder: A Case-Control Seroprevalence Study in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco; Luis Omar Berumen-Segovia; Yazmin Elizabeth Torres-Prieto; Sergio Estrada-Martinez; Alma Rosa Perez-Alamos; Maria Nalleli Ortiz-Jurado; Gabriel Molotla-de-Leon; Isabel Beristain Garcia; Elizabeth Rabago-Sanchez; Oliver Liesenfeld
Journal:  J Clin Med Res       Date:  2016-05-29

10.  Humans with latent toxoplasmosis display altered reward modulation of cognitive control.

Authors:  Ann-Kathrin Stock; Danica Dajkic; Hedda Luise Köhling; Evelyn Heintschel von Heinegg; Melanie Fiedler; Christian Beste
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.